BMI at the baseline | Gender |
p
| OR | 95% CI |
---|
BMI < 25 | Men | 0.397 | 0.771 | 0.423–1.406 |
Women | 0.242 | 0.743 | 0.451–1.223 |
BMI 25–29.9 | Men | < 0.05 | 0.804 | 0.636–0.997 |
Women | < 0.05 | 0.732 | 0.568–0.937 |
BMI ≥ 30 | Men | < 0.0001 | 0.586 | 0.481–0.713 |
Women | < 0.001 | 0.730 | 0.611–0.876 |
-
BMI body mass index (kg/m2); CI confidence interval; OR odds ratio of the association between BMI decrease and uncontrolled hypertension at the end of the follow-up (compared to cohorts with no significant BMI change); P probability (association assessed using binary logistic regression, age, baseline systolic and diastolic blood pressure, creatinine, and number of minimal effective doses of antihypertensive drugs at the beginning and at the end of the follow-up were included in the analysis as possible confounders)